typhim vi 25micrograms/0.5ml vaccine solution for injection pre-filled syringes
sanofi - salmonella typhi vi capsular polysaccharide - solution for injection - 50microgram/1ml
prepandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted) novartis vaccines and diagnostics
novartis vaccines and diagnostics s.r.l. - influenza virus surface antigens (haemagglutinin and neuraminidase) of strain a/viet nam/1194/2004 (h5n1) - influenza, human, immunization, disease outbreaks - vaccines, - active immunisation against h5n1 subtype of influenza a virus., this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain., prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.,
apvma veterinary use permit 80605- salmonella buz inactivated vaccine/ cattle/ salmonellosis
apvma permit - salmonella enterica - vaccine
respisure mh/hps vaccine (inactivated)
zoetis - vaccine - mycoplasma hyopneum.+vaccine - glassers - parenteral liquid/solution/suspension - vaccine - pigs | boar | gilt | piglet | sow | swine - glassers disease | growth suppression | haemophilus parasuis serovar 13 | haemophilus parasuis serovar 4 | haemophilus parasuis serovar 5 | lung lesions | mycoplasma hyopneumoniae | polyserositis | respiratory disease | reduction of lung lesions | respiratory disease | swine enzootic pneumonia
protech c2i canine coronavirus & leptospira copenhageni killed vaccine
boehringer ingelheim animal health australia pty. ltd. - leptospira icterohaemorrhagiae antigen; canine coronavirus vaccine - antigen - misc. vaccines or anti sera - leptospira icterohaemorrhagiae antigen vaccine-antigen active 1.0 rp; canine coronavirus vaccine - antigen vaccine-viral active 1.62 rp - immunotherapy - dog - over 6 weeks old - canine adenovirus - type 1 | canine adenovirus - type 2 | canine coronavirus | canine distemper | canine parainfluenza | canine parvovirus | leptospira icterohaemorrhagiae | parvovirus
websters bursavac k infectious bursal disease vaccine (oil adjuvanted inactivated v877 strain virus)
zoetis australia pty ltd - infectious bursal disease virus (ibd) strain v877 - misc. vaccines or anti sera - infectious bursal disease virus (ibd) strain v877 vaccine-viral active 0.0 p - immunotherapy - fowl - infectious bursal disease | vaccine | bursal disease | equine rotavirus
apvma limited use permit 14560- autogenous salmonella vaccine for poultry/ poultry/ salmonella
apvma permit - vaccine - salmonella spp. - vaccine
typhim vi solution
sanofi pasteur limited - salmonella typhi vi capsular polysaccharide vaccine - solution - 25mcg - salmonella typhi vi capsular polysaccharide vaccine 25mcg - vaccines
typherix liquid
glaxosmithkline inc - salmonella typhi vi capsular polysaccharide vaccine - liquid - 25mcg - salmonella typhi vi capsular polysaccharide vaccine 25mcg - vaccines
vivotif-b capsule
rebel distributors corp - salmonella enterica subsp. enterica serovar typhi (unii: 760t5r8b3o) (salmonella enterica subsp. enterica serovar typhi - unii:760t5r8b3o) - salmonella enterica subsp. enterica serovar typhi 2 [cfu] - vivotif (typhoid vaccine live oral ty21a) is indicated for immunization of adults and children greater than 6 years of age against disease caused by salmonella typhi . routine typhoid vaccination is not recommended in the united states of america. selective immunization against typhoid fever is recommended for the following groups: 1) travelers to areas in which there is a recognized risk of exposure to s. typhi , 2) persons with intimate exposure (e.g. household contact) to a s. typhi carrier, and 3) microbiology laboratorians who work frequently with s. typhi (7). there is no evidence to support the use of typhoid vaccine to control common source outbreaks, disease following natural disasters or in persons attending rural summer camps. not all recipients of vivotif will be fully protected against typhoid fever. vaccinated individuals should continue to take personal precautions against exposure to typhoid organisms. the vaccine will not afford protection against species of salmonella other than salmonella